您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > LGD-2226
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
LGD-2226
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
LGD-2226图片
CAS NO:328947-93-9
包装:5 mg
市场价:7000元

产品介绍

产品描述

LGD-2226 is a selective and orally active androgen receptor modulator (EC50: 0.2 nM, Ki: 1.5 nM for the human androgen receptor). LGD-2226 can be used for muscle wasting, osteoporosis, and sexual dysfunction.

体外活性

LGD-2226 occupies the same binding pocket as dihydrotestosterone (DHT), the protein backbone is superposable to that observed with DHT. The trifluoroethyl groups of LGD-2226 occupy the same space in the receptor as the C and D rings of the steroid. GLN711 forms an additional hydrogen bond with the quinolone NH of LGD-2226. Just like the carbonyl group of DHT, the quinolone carbonyl forms hydrogen bond interactions with GLN711 and ARG752 [1].

体内活性

LGD-2226 has weak trophic effects on the prostate. LGD-2226 (100 mg/kg) treatment, is required to maintain prostate weight at intact levels. LGD-2226 (1-100 mg/kg; p.o.; daily; for 2 weeks; adult oORDX rats) has a pronounced effect on the levator ani muscle, maintaining the muscle weight at the eugonadal levels at an approximate 3 mg/kg dose. These data clearly show the tissue selectivity of LGD-2226[1].

Cas No.

328947-93-9

分子式

C14H9F9N2O

分子量

392.22

储存和溶解度

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years